Melanoma
Conditions
Brief summary
The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.
Interventions
Tissue will be obtained from a previous biopsy if available, or if unavailable, tissue will be collected from a scheduled biopsy. About3-4 teaspoons of blood will be collected.
Sponsors
Vanderbilt-Ingram Cancer Center
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Pathologically-proven diagnosis of melanoma. * Patient must have a test or procedure that has the potential to provide left-over tissue that can be banked for future research purposes OR the patient has already had a diagnostic or therapeutic procedure but who has not yet been approached to participate is also eligible.
Exclusion criteria
* Any patient with significant contraindications to venipuncture (e.g., severe anemia) will be excluded from blood collection procedures. However, if the patient provides consent and a paraffin-embedded block or 10-15 unstained slides of their tissue diagnosis, they will not be excluded from this protocol. * Any patient unable or unwilling to provide consent.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Molecular changes in patients' melanoma tissue | at 120 months | Tissue is collected upon consent or upon receipt of parafin block, primary aim will be met when all tissues are collected and analyzed at conclusion of study. Intent is to aid patients and their treating physician when making treatment decisions. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Improve the time between ordering the test and results entry into medical records | 120 months | To enhance the speed and detail of molecular mutation profiling of melanoma |
Countries
United States
Contacts
Primary ContactVanderbilt-Ingram Service for Timely Access
Outcome results
None listed